Turning Point Brands (0T5) AI Stock Analysis
Turning Point Brands
(Frankfurt:0T5)
No summary available
Turning Point Brands (0T5) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 1.35B
- Dividend Yield
- 0.46%
- Average Volume (3M)
- 30
- Price to Earnings (P/E)
- 28.3
- Beta (1Y)
- 0.78
- Revenue Growth
- 12.11%
- EPS Growth
- -9.46%
- Country
- Germany
- Employees
- 484
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Tobacco
Turning Point Brands Business Overview & Revenue Model
Company Description
Turning Point Brands, Inc., along with its affiliated companies, is engaged in the creation, promotion, and distribution of a diverse array of branded consumer products. Its operations are structured into three distinct divisions: Zig-Zag Products, S...
Turning Point Brands Earnings Call Summary
The call was strongly optimistic, led by substantial Modern Oral growth, raised Modern Oral revenue guidance, expanding retail distribution, positive ALP traction, and continued investment in long-term brand and manufacturing capabilities. These positives outweighed lower adjusted EBITDA, higher SG&A, Zig-Zag softness, lower heritage revenue, reduced Stoker's gross margin, and PMTA timing uncertainty.
Q2-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Guidance calls for chain store count to increase 70% year-over-year by the end of 2026, sales force growth of approximately 50% this year, and, subject to regulatory approval, U.S. manufacturing to launch by the end of the year; once fully scaled, the company believes it can achieve gross margins of approximately 70%. Full year 2026 Modern Oral gross sales guidance is $330 million-$350 million, up from $280 million-$300 million, and net sales guidance is $260 million-$270 million, up from $210 million-$225 million; full-year EBITDA guidance remains $70 million-$90 million, inclusive of increased nicotine pouch investments, budgeted 2026 CapEx remains $4 million-$5 million, excluding projects related to Modern Oral, and the company expects to spend an additional $3 million-$5 million in 2026 in support of its PMTA applications.
Turning Point Brands Risk Analysis
Turning Point Brands disclosed 46 risk factors in its most recent earnings report. Turning Point Brands reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
0 New RisksTurning Point Brands Peers Comparison
Overall Rating
RLX78Outperform
BTI68Neutral
PM68Neutral
MO65Neutral
XXII40Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $2.00B | 13.48 | 6.20% | 6.79% | 59.23% | 39.66% | |
| 68Neutral | $134.19B | 16.15 | 13.38% | 5.27% | 4.47% | 117.22% | |
| 68Neutral | $329.31B | 29.42 | -119.68% | 2.98% | 7.91% | 24.06% | |
| 65Neutral | $129.76B | 16.03 | -279.72% | 5.53% | 2.41% | -7.63% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 40Underperform | $46.78M | 0.00 | -20.47% | ― | -27.44% | 99.95% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:0T5 | Turning Point Brands Inc | 62.30 | -24.88 | -28.53% | |
| MO | Altria | 76.12 | 22.22 | 41.21% | |
| BTI | British American Tobacco | 60.89 | 8.58 | 16.41% | |
| PM | Philip Morris International | 197.88 | 48.11 | 32.12% | |
| XXII | 22nd Century Group | 1.55 | -22444.45 | -99.99% | |
| RLX | Rlx Technology, Inc. | 1.61 | -0.60 | -27.25% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.